Technology

Bond Prices Sneak Higher Ahead of Heavy Data, Fed Speak and Supply — 10-Year 2.941%

Bond Prices Sneak Higher Ahead of Heavy Data, Fed Speak and Supply — 10-Year 2.941%

US Treasury prices were little changed, with prices slightly higher, dipping yields with longer dated notes mildly outperforming. The 10-year yield was down near 2.941% versus a 2.942% close. The two-year was also flat at 2.707%. Core European sovereign prices weakened modestly from earlier highs, with the German Bund yield up 1.5 basis points from Friday at 0.399% after testing […]

Tesla Begins to Deliver Model 3 on ‘First-Come, First-Served’ Basis; Promotes Guillen to President of Automotive

Tesla Begins to Deliver Model 3 on ‘First-Come, First-Served’ Basis; Promotes Guillen to President of Automotive

Tesla (TSLA) will begin delivering Model 3 automobiles “immediately” on a “first come, first served” basis to reservation holders who have yet to place an order for a specific car. According to Electrek, these are mainly consumers waiting for the base $35,000 model with the standard battery pack. Tesla notified reservation holders through an email that “as a first day […]

Chip Maker Shares Tumble on Memory Market Outlook, KLA-Tencor Comment

Chip Maker Shares Tumble on Memory Market Outlook, KLA-Tencor Comment

Shares of chip makers plunged in early Thursday trading following comments made by KLA-Tencor (KLAC) at the Citi Global Technology Conference in New York and concerns raised by analysts regarding the outlook for memory markets heading into the final quarter of the year, media reported. KLA-Tencor, a provider of process control and yield management systems, plummeted as much as 9%, […]

Histogenics Says Phase 3 Trial of NeoCart Failed to Meet Primary Endpoint

Histogenics Says Phase 3 Trial of NeoCart Failed to Meet Primary Endpoint

Shares of Histogenics (HSGX), a clinical-stage company focused on the development of restorative cell therapies, fell nearly 64% in pre-market trading Wednesday after the company said its phase 3 trial of NeoCart failed to meet the primary endpoint of a statistically significant improvement in pain and function in a dual threshold responder analysis one year after treatment as compared to […]

bluebird bio Says Phase 2/3 Starbeam Study Meets Enrollment Goal

bluebird bio Says Phase 2/3 Starbeam Study Meets Enrollment Goal

bluebird bio (BLUE) reported Wednesday that its phase 2/3 Starbeam study of its investigational Lenti-D gene therapy in boys 17 years of age and under with cerebral adrenoleukodystrophy (CALD), has met its enrollment goal; it also reported initial data from ALD-103, the ongoing observational study of outcomes from allogeneic hematopoietic stem cell transplant (allo-HSCT) in boys 17 years of age […]

Workday Ramps up Full Year Outlook After Second Quarter Results Top Street View

Workday Ramps up Full Year Outlook After Second Quarter Results Top Street View

Cloud computing company Workday (WDAY) raised its full year revenue outlook late on Tuesday as it posted better-than-expected results for its top and bottom lines which was buttressed by a jump in subscriptions. The Pleasanton, California-headquartered company, which provides enterprise cloud applications for financial management and human capital management, generated total revenue of $671.7 million in the quarter ended July […]

Helios and Matheson Crumbles To Record Low on Q2 Loss

Shares of Helios and Matheson Analytics (HMNY), the parent company of MoviePass, fell to a new all-time low of $0.03 in early Wednesday trading following the release of disappointing Q2 results in which the company said it has “substantial doubt” it can continue as a going concern. “Without raising additional capital, there is substantial doubt about the Company’s ability to […]

Discovery Communications Misses Views on Adjusted Earnings

Discovery Communications Misses Views on Adjusted Earnings

Discovery Communications (DISCA) released disappointing quarterly results on Tuesday that sent its stock price into the red, with the broadcaster reporting “tepid underlying growth trends,” according to Pivotal Research. Adjusted earnings per diluted share slipped to $0.66 from $0.68, missing the consensus on Capital IQ for $0.86 a share. Revenue jumped 63% to $2.85 billion, in line with the Street’s […]